Investigating the effect of saffron capsules on irritable bowel syndrome
Phase 3
- Conditions
- Irritable bowel syndrome.Irritable bowel syndrome
- Registration Number
- IRCT20240223061091N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 57
Inclusion Criteria
All patients with irritable bowel syndrome
Exclusion Criteria
Age less than 18 years
Having a chronic gastrointestinal disease such as IBD
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method